Indication
Sulfadiazine toxicity
Sulfadiazine toxicity refers to the spectrum of adverse drug reactions, acute overdose manifestations, or organ toxicities resulting from systemic exposure to the sulfonamide antibiotic sulfadiazine. Read more about Sulfadiazine toxicity
45 drugs 36 manufacturers
Drugs that treat it
Common Sulfadiazine toxicity therapies.
LEUCOVORIN CALCIUM
LEVOLEUCOVORIN CALCIUM
KHAPZORY (levoleucovorin)
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSulfadiazine toxicity refers to the spectrum of adverse drug reactions, acute overdose manifestations, or organ toxicities resulting from systemic exposure to the sulfonamide antibiotic sulfadiazine.
It predominantly impacts the renal, dermatologic, hematologic, and hepatic systems.
Defining clinical and pathophysiologic features include crystalluria leading to obstructive acute kidney injury and nephrolithiasis due to the precipitation of insoluble drug metabolites in acidic urine, idiosyncratic severe cutaneous adverse reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis, bone marrow suppression manifesting as leukopenia, agranulocytosis, or thrombocytopenia, and kernicterus in neonates secondary to displacement of bilirubin from albumin binding sites.
- nih.gov
Sulfadiazine toxicity refers to the spectrum of adverse drug reactions, acute overdose manifestations, or organ toxicities resulting from systemic exposure to the sulfonamide antibiotic sulfadiazine It predominantly impacts the renal, dermatologic, hematologic, and hepatic systems
- nih.gov
Sulfadiazine toxicity refers to the spectrum of adverse drug reactions, acute overdose manifestations, or organ toxicities resulting from systemic exposure to the sulfonamide antibiotic sulfadiazine
- patsnap.com
It predominantly impacts the renal, dermatologic, hematologic, and hepatic systems Defining clinical and pathophysiologic features include crystalluria leading to obstructive acute kidney injury and nephrolithiasis due to the precipitation of insoluble drug metabolites in acidic urine, idiosyncratic severe cutaneous adverse reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis, bone marrow suppression manifesting as leukopenia, agranulocytosis, or thrombocytopenia, and kernict...
- mayoclinic.org
Defining clinical and pathophysiologic features include crystalluria leading to obstructive acute kidney injury and nephrolithiasis due to the precipitation of insoluble drug metabolites in acidic urine, idiosyncratic severe cutaneous adverse reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis, bone marrow suppression manifesting as leukopenia, agranulocytosis, or thrombocytopenia, and kernicterus in neonates secondary to displacement of bilirubin from albumin binding sites
Personalize your experience
Follow Sulfadiazine toxicity and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.